Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population

Journal of Infectious Diseases

Volumn 179, Issue 4, 1999, Pages 915-923

  Van Loo, Inge H M ^b   Van der Heide, Han G J ^b   Nagelkerke, Nico J D ^b   Verhoef, Jan ^b   Mooi, Frits R ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; BACTERIUM ISOLATE; BORDETELLA PERTUSSIS; DNA FINGERPRINTING; GENOTYPE; NETHERLANDS; NONHUMAN; PERTUSSIS; POPULATION STRUCTURE; PRIORITY JOURNAL; STRAIN DIFFERENCE; VACCINATION;

BACTERIAL VACCINES; BORDETELLA PERTUSSIS; DNA, BACTERIAL; GENOTYPE; NETHERLANDS; TIME FACTORS; VACCINATION;

EID: 3042793468     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314690     Document Type: Article

References (26)

1. Cohen HH. Development of pertussis vaccine production and control in the National Institute of Public Health in The Netherlands during the years 1950 1962. Ant Van Leeuwenhock 1963; 29:183-201.
2. de Melker HE, Conyn-van Spaendock MAE, Rümke HC, van-Wijngaarden JK, Mooi FR, Schellekens JFP. Pertussis in the Netherlands: an outbreak despite high levels of immunization with whole cell vaccine. Emerg Infect Dis 1997; 3:175-8.
3. Andrews R, Herceq A, Roberts C. Pertussis notifications in Australia. Commun Dis Intell 1997; 21:145-8.
4. Bass JW, Wittler RR. Return of epidemic pertussis in the United States. Pediatr Infect Dis J 1994; 13:343-5.
5. Blystad H, Bãckman-Breidvick G, Eide Anestad KA. Meldingssystem For Smittsiomme Sykdommer (MSIS)-rapport. Oslo, MSIS, 1997:week 43.
6. De Serres, G, Boulianne N, Douville Fradet M, Duval B. Pertussis in Quebec: ongoing epidemic since the late 1980s. Can Commun Dis Rep 1995; 15: 45-8.
7. Bass JW, Stephenson SR. The return of pertussis. Pediatr Infect Dis J 1987;6: 141-4.
8. Nennig ME, Shinefield HR, Edwards KM, Black SB, Fireman BH. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996; 275:1672-4.
9. Willems RJL, Mooi FR. From whole cell to acellular vaccines. Rev Med Microbiol 1996; 7:13-21.
10. Mooi FR, vanOirschot H, Heuvelman K, vanderHeide GHJ, Gaastra W, Willems RJL. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in the Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun 1998; 66:670-5.
11. van der Zee A, Vernooij S, Peeters M, VanEmbden JDA, Mooi FR. Dynamics of the population structure of Bordetella pertussis as measured by IS1002-associated RFLP: comparison of pre- and post-vaccination strains and global distribution. Microbiology 1996; 142:3479-85.
12. Verwey WF, Thiele EH, Sage DN, Schuchardt LT. A simplified liquid culture medium for growth of Haemophilus pertussis. J Bacteriol 1949; 58:127-34.
13. Mooi FR, van der Heide HGJ, ter Avest AR, Wellinder KG, Livey I. van der Zeijst BAM, Gaastra W. Characterization of fimbrial subunits from Bordetella species. Microb Pathog 1987; 2;473-84.
14. Nei M, Tajima F. DNA polymorphism detectable by restriction endonucleases. Genetics 1981; 97:145-63.
15. Urwin G, Krohn JA, Deaverrobinson K, et al. Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiologic characteristics in the H. influenzae serotype b vaccine era. Clin Infect Dis 1996; 22: 1069-76.
16. Rota PA, Bloom AE, Vanchiere JA, Bellini WJ. Evolution of the nucleo-protein and matrix genes of wild-type strains of measles virus isolated from recent epidemics. Virology 1994; 198:724-30.
17. Tamin A, Rota PA, Zhong-de Wang, Heath JL, Anderson LJ, Bellini WJ. Antigenic analysis of current wild type and vaccine strains of measles virus. J Infect Dis 1994; 170:795-801.
18. de Moissac YR, Ronald SL, Peppler MS. Use of pulsed-field gel electrophoresis for the epidemiological study of Bordetella pertussis in a whooping cough outbreak. J Clin Microbiol 1994; 32:398-402.
19. Syedabubakar SN, Matthews RC, Preston NW, Owen D, Hillier V. Application of pulsed field electrophoresis to the 1993 epidemic of whooping cough in the UK. Epidemiol Infect 1995; 115:101-13.
20. Beall B, Cassiday PK, Sanden GN. Analysis of Bordetella pertussis isolates from an epidemic by pulsed-field gel electrophoresis. J Clin Microbiol 1995; 33:3083-6.
21. Musser JM, Hewlett EL, Peppler MS, Selander RK. Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol 1986; 166: 230-7.
22. Sreevatsan S, Pan X, Stockbauer KE, et al. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci USA 1997; 94: 9869-74.
23. van Embden JDA, Crawford JT, Dale JW, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31:406-9.
24. Roberts M, Tite J, Fairweather N, Dougan G, Charles I. Recombinant P69/ pertactin: immunogenicity and protection of mice against Bordetella pertussis infection. Vaccine 1992; 10:43-52.
25. Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 1996; 334:341-8.
26. Olin P, Rasmussen F, Gustafson L, Hallander HO, Heijbel H. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccines. Lancet 1997; 350:1569-77.